ABA Autism denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for aba autism are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Applied Step Therapy to ABA Therapy — and Why You Can Appeal

Step therapy (sometimes called "fail-first") requires a patient to try and fail one or more alternative treatments before the insurer will cover the requested therapy. When applied to ABA for Autism Spectrum Disorder, this denial is particularly contestable. ABA is typically the first-line, evidence-based behavioral intervention for ASD — there is no scientifically established behavioral therapy that serves as a prerequisite to it. Requiring a child with ASD to fail an unrelated or less-intensive intervention before accessing ABA can cause irreversible developmental harm during a critical window, which supports an expedited appeal.

Many states have enacted step-therapy reform laws requiring exceptions when the required first-step therapy is contraindicated, has already been tried, or when delay would cause irreversible harm. Check whether your state's law applies to this plan.

## Federal Appeal Framework

• ACA §2719 / External Review: Independent external review is available after an upheld internal appeal. The window is approximately 180 days from denial. Expedited review is strongly warranted when developmental regression is occurring.
• ERISA §503: Full-and-fair internal review with a written explanation of exactly which step-therapy requirement was not met.
• MHPAEA: If Aetna does not apply equivalent step-therapy requirements to comparable medical rehabilitation services, that disparity is independently appealable under parity law.

## Documentation to Gather

• Documentation of prior treatments tried: Dates, durations, providers, and outcomes for any behavioral, educational, or developmental interventions already completed.
• Clinical rationale for skipping a step: The treating physician or BCBA should document in writing why the required first-step treatment is clinically inappropriate, has already been exhausted, or why delay would cause serious harm.
• Urgency evidence: Documentation of active regression, critical developmental windows, safety concerns, or functional deterioration that supports expedited review.
• Diagnosis confirmation: Licensed clinician's written ASD diagnosis.
• Aetna's step-therapy policy: Obtain the specific policy to identify every stated exception (prior failure, contraindication, urgent need) and document that one or more exceptions apply.

## Criteria-Mapping Structure

For each step-therapy requirement in Aetna's policy, document either (a) prior completion with dates and outcomes, or (b) the clinical reason why that step is inappropriate and the chart evidence supporting it. Address each stated exception in the policy and show that at least one applies to this case.